NewAmsterdam Pharma Company N.V. (NAMS) Revenue History

NewAmsterdam Pharma Company N.V. (NAMS) annual and quarterly revenue history with charts. Get revenue data in Excel with MarketXLS.

Revenue Data

PeriodTotalRevenue
2022-12-31$102.69M
2023-12-31$14.09M
2024-12-31$45.56M

Get NewAmsterdam Pharma Company N.V. Data in Excel

Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.

Try: =hf_Revenue("NAMS", 2024)

BUY NOW